BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 14671929)

  • 1. [CFTR and transepithelial ionic transport abnormalities in cystic fibrosis].
    Becq F
    Arch Pediatr; 2003 Sep; 10 Suppl 2():325s-332s. PubMed ID: 14671929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
    Kunzelmann K; Mall M
    Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unified Airway-Cystic Fibrosis.
    Cho DY; Grayson JW; Woodworth BA
    Otolaryngol Clin North Am; 2023 Feb; 56(1):125-136. PubMed ID: 36266104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
    Reihill JA; Douglas LEJ; Martin SL
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion channels as targets to treat cystic fibrosis lung disease.
    Martin SL; Saint-Criq V; Hwang TC; Csanády L
    J Cyst Fibros; 2018 Mar; 17(2S):S22-S27. PubMed ID: 29102290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis].
    Chinet T
    Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CFTR in airway disease.
    Pilewski JM; Frizzell RA
    Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Cystic Fibrosis Transmembrane Conductance Regulator Deficiency.
    Cho DY; Woodworth BA
    Adv Otorhinolaryngol; 2016; 79():78-85. PubMed ID: 27466849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.
    Proesmans M; Vermeulen F; De Boeck K
    Eur J Pediatr; 2008 Aug; 167(8):839-49. PubMed ID: 18389279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
    Zabner J; Wadsworth SC; Smith AE; Welsh MJ
    Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ion transporters in the lungs. Use as therapeutic targets].
    Varas SM; Pérez Chaca MV; Gómez NN
    Medicina (B Aires); 2019; 79(4):303-314. PubMed ID: 31487254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
    Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
    Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis.
    Dean N; Ranganath NK; Jones B; Zhang S; Skinner D; Rowe SM; Sorscher EJ; Woodworth BA
    Int Forum Allergy Rhinol; 2014 Jul; 4(7):565-70. PubMed ID: 24733748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
    Knowles MR; Olivier K; Noone P; Boucher RC
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology.
    Larbig M; Jansen S; Dorsch M; Bernhard W; Bellmann B; Dorin JR; Porteous DJ; Von Der Hardt H; Steinmetz I; Hedrich HJ; Tuemmler B; Tschernig T
    Pathobiology; 2002-2003; 70(2):89-97. PubMed ID: 12476034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia.
    Ostedgaard LS; Randak C; Rokhlina T; Karp P; Vermeer D; Ashbourne Excoffon KJ; Welsh MJ
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1937-42. PubMed ID: 12578973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.